Shensi Shen

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Venues

Signal transduction and targeted therapy

Nature reviews. Clinical oncology

Nature medicine

Nature reviews. Cancer

Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences Sep 01 2003 - Jul 01 2009

China

PHD

Publications

Jian Zhang, Kejia Zhao, Wenjing Zhou, Ran Kang, Shiyou Wei, Yueli Shu, Cheng Yu, Yin Ku, Yonghong Mao, Hao Luo, Juqin Yang, Jiandong Mei, Qiang Pu, Senyi Deng, Zhengyu Zha, Gang Yuan, Shensi Shen, Yaohui Chen, Lun-Xu Liu
Tet methylcytosine dioxygenase 2 (TET2) deficiency elicits EGFR-TKI (tyrosine kinase inhibitors) resistance in non-small cell lung cancer. Signal transduction and targeted therapy 9 (1) (2024)
Bo Dong, Mengyao Wang, Kaixiu Li, Zuwei Li, Lun-Xu Liu, Shensi Shen
Plasma proteometabolome in lung cancer: exploring biomarkers through bidirectional Mendelian randomization and colocalization analysis. Human molecular genetics (2024)
Jian Zhang, Kejia Zhao, Wenjing Zhou, Ran Kang, Shiyou Wei, Yueli Shu, Cheng Yu, Yin Ku, Yonghong Mao, Hao Luo, Juqin Yang, Jiandong Mei, Qiang Pu, Senyi Deng, Zhengyu Zha, Gang Yuan, Shensi Shen, Yaohui Chen, Lun-Xu Liu
Tet methylcytosine dioxygenase 2 (TET2) deficiency elicits EGFR-TKI (tyrosine kinase inhibitors) resistance in non-small cell lung cancer. Signal transduction and targeted therapy 9 (1) (2024)
Mariangela Russo, Mengnuo Chen, Elisa Mariella, Haoning Peng, Sumaiyah K Rehman, Elena Sancho, Alberto Sogari, Tzen S Toh, Nathalie Q Balaban, Eduard Batlle, René Bernards, Mathew J Garnett, Matthew Hangauer, Eleonora Leucci, Jean-Christophe Marine, Catherine A O'Brien, Yaara Oren, E Elizabeth Patton, Caroline Robert, Susan M Rosenberg, Shensi Shen, Alberto Bardelli
Cancer drug-tolerant persister cells: from biological questions to clinical opportunities. Nature reviews. Cancer (2024)
Jian Zhang, Kejia Zhao, Wenjing Zhou, Ran Kang, Shiyou Wei, Yueli Shu, Cheng Yu, Yin Ku, Yonghong Mao, Hao Luo, Juqin Yang, Jiandong Mei, Qiang Pu, Senyi Deng, Zhengyu Zha, Gang Yuan, Shensi Shen, Yaohui Chen, Lun-Xu Liu
Tet methylcytosine dioxygenase 2 (TET2) deficiency elicits EGFR-TKI (tyrosine kinase inhibitors) resistance in non-small cell lung cancer. Signal transduction and targeted therapy 9 (1) (2024)
Jian Zhang, Kejia Zhao, Wenjing Zhou, Ran Kang, Shiyou Wei, Yueli Shu, Cheng Yu, Yin Ku, Yonghong Mao, Hao Luo, Juqin Yang, Jiandong Mei, Qiang Pu, Senyi Deng, Zhengyu Zha, Gang Yuan, Shensi Shen, Yaohui Chen, Lun-Xu Liu
Tet methylcytosine dioxygenase 2 (TET2) deficiency elicits EGFR-TKI (tyrosine kinase inhibitors) resistance in non-small cell lung cancer. Signal transduction and targeted therapy 9 (1) (2024)
Yi Pu, Lu Li, Haoning Peng, Lunxu Liu, Dominique Heymann, Caroline Robert, François Vallette, Shensi Shen
Drug-tolerant persister cells in cancer: the cutting edges and future directions. Nature reviews. Clinical oncology (2023)
Giuseppina Claps, Sara Faouzi, Virginie Quidville, Feras Chehade, Shensi Shen, Stéphan Vagner, Caroline Robert
The multiple roles of LDH in cancer. Nature reviews. Clinical oncology 19 (12) (2022)
Isabelle Girault, Julien Adam, Shensi Shen, Séverine Roy, Caroline Brard, Sara Faouzi, Emilie Routier, Jeremy Lupu, Sarah Warren, Kristina Sorg, SuFey Ong, Pascale Morel, Jean Yves Scoazec, Stéphan Vagner, Caroline Robert
A PD-1 /PD-L1 proximity assay as a theranostic marker for PD-1 blockade in patients with metastatic melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Michaël Cerezo, Caroline Robert, Lun-Xu Liu, Shensi Shen
The Role of mRNA Translational Control in Tumor Immune Escape and Immunotherapy Resistance. Cancer research 81 (22) (2021)
Shensi Shen, Jean Clairambault
Cell plasticity in cancer cell populations. F1000Research 9 (2020)
William Rostain, Shensi Shen, Teresa Cordero, Guillermo Rodrigo, Alfonso Jaramillo
Engineering a Circular Riboregulator in Escherichia coli . Biodesign research 2020 (2020)
Shensi Shen, Xiaoxiao Sun
Emerging role of mRNA epitranscriptomic regulation in chemoresistant cancer cells. Molecular & cellular oncology 7 (3) (2020)
Shensi Shen, Sara Faouzi, Amandine Bastide, Sylvain Martineau, Hélène Malka-Mahieu, Yu Fu, Xiaoxiao Sun, Christine Mateus, Emilie Routier, Severine Roy, Laurent Desaubry, Fabrice Andre, Alexander Eggermont, Alexandre David, Jean Yves Scoazec, Stéphan Vagner, Caroline Robert
An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cells. Nature communications 10 (1) (2019)
Michaël Cerezo, Ramdane Guemiri, Sabine Druillennec, Isabelle Girault, Hélène Malka-Mahieu, Shensi Shen, Delphine Allard, Sylvain Martineau, Caroline Welsch, Sandrine Agoussi, Charlène Estrada, Julien Adam, Cristina Libenciuc, Emilie Routier, Séverine Roy, Laurent Désaubry, Alexander M Eggermont, Nahum Sonenberg, Jean Yves Scoazec, Alain Eychène, Stéphan Vagner, Caroline Robert
Translational control of tumor immune escape via the eIF4F-STAT1-PD-L1 axis in melanoma. Nature medicine 24 (12) (2018)

Shensi Shen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Shensi Shen